Over the last few years, more small batch projects are emerging as pharmacuetical companies are developing therapies targeting rare diseases. Along with those products comes an increase in outsourcing projects requiring short lead times for aseptic filling.
In April 2019, Singota Solutions was contacted by the Director of Formulation and Drug Product Manufacture of a small, research-focused biotechnology company looking to develop a relationship with a CMO partner. Their small molecule, Phase I / II project was several months out, so a general discussion occurred about Singota’s capabilities. In July 2019, three months after contacting and learning more about Singota, the client received incredibly positive results in the clinic for their current program and was instructed by leadership to push ahead quickly with an aseptic fill for another trial. They urgently needed to get their finished drug product clinical supplies to their distributor by December to make it in the clinic by January 2020.